Literature DB >> 4327893

[Bilateral study on renal elimination of urea, electrolytes and glucose in asymmetric pyelonephritis].

H Ludwig.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4327893     DOI: 10.1007/bf01513468

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  34 in total

1.  THE ANGIOTENSIN-INFUSION TEST. A NEW APPROACH TO THE DIFFERENTIAL DIAGNOSIS OF RENOVASCULAR HYPERTENSION.

Authors:  N M KAPLAN; J G SILAH
Journal:  N Engl J Med       Date:  1964-09-10       Impact factor: 91.245

Review 2.  RENIN-ANGIOTENSIN SYSTEM, ALDOSTERONE, AND SODIUM BALANCE.

Authors:  F GROSS; H BRUNNER; M ZIEGLER
Journal:  Recent Prog Horm Res       Date:  1965

3.  [On physiological urinary glucose excretion in persons with normal metabolism].

Authors:  H WEICKER; H SCHOENTHAL; H E RENSCHLER
Journal:  Klin Wochenschr       Date:  1963-02-15

4.  A rapid and precise method for the determination of urea.

Authors:  J K FAWCETT; J E SCOTT
Journal:  J Clin Pathol       Date:  1960-03       Impact factor: 3.411

5.  Pyelonephritis.

Authors:  C R KLEEMAN; W HEWITT; L B GUZE
Journal:  J Am Med Assoc       Date:  1960-05-21

6.  Significance of some renal function tests in the early diagnosis of chronic pyelonephritis.

Authors:  A KASANEN; H SALMI
Journal:  Acta Med Scand       Date:  1959-10-16

7.  JUXTAGLOMERULAR CELLS AS THE SOURCE OF RENIN: FURTHER STUDIES WITH THE FLUORESCENT ANTIBODY TECHNIQUE AND THE EFFECT OF PASSIVE TRANSFER OF ANTIRENIN.

Authors:  P M HARTROFT; L E SUTHERLAND; W S HARTROFT
Journal:  Can Med Assoc J       Date:  1964-01-25       Impact factor: 8.262

8.  A theoretical treatment of glucose reabsorption in the kidney.

Authors:  A S BURGEN
Journal:  Can J Biochem Physiol       Date:  1956-05

9.  [Renin-angiotensin-aldosterone system in hypertensive conditions].

Authors:  P Weidmann; W Siegenthaler
Journal:  Dtsch Med Wochenschr       Date:  1967-10-27       Impact factor: 0.628

10.  Glucose titration studies in patients with chronic progressive renal disease.

Authors:  R E Rieselbach; S W Shankel; E Slatopolsky; H Lubowitz; N S Bricker
Journal:  J Clin Invest       Date:  1967-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.